Lecanemab for Alzheimer Disease: Is It Worth It?

Neurology. 2024 Apr 9;102(7):e209265. doi: 10.1212/WNL.0000000000209265. Epub 2024 Mar 14.

Authors

Sarah E Nelson¹, Oscar L Lopez¹

Affiliation

¹ From the Tufts Medical Center (S.E.N.), Boston, MA; University of Pittburgh (O.L.L.), PA.

PMID: 38484273
DOI: 10.1212/WNL.0000000000209265

No abstract available

Publication types

Editorial

MeSH terms

Alzheimer Disease*
Antibodies, Monoclonal, Humanized*
Humans

Substances

lecanemab
Antibodies, Monoclonal, Humanized